ArticleScience China. Life sciences2026
A species-specific protein corona determines osteogenic fate of multi-walled carbon nanotubes by modulating macrophage polarization.
Article in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multi-walled carbon nanotubes (MWCNTs) have emerged as promising candidates for bone tissue engineering due to their excellent biocompatibility, mechanical strength, and chemical stability. However, disparities often exist between their osteogenic performance in vitro and in vivo. The formation of protein corona on biomaterials is a key factor that may govern these biological outcomes. This study investigated how the distinct protein corona compositions in mouse serum (MS) and fetal bovine serum (FBS) modulate the immune recognition and osteogenic capacity of MWCNTs, thereby mimicking in vitro and in vivo environments, respectively. It was demonstrated that the MS-derived corona complexes, enriched with immunoreactive proteins such as complement 3, potently induced a pro-inflammatory M1 response via recognizable immune signals in both Raw264.7 cells and a mouse calvarial defect model. In contrast, FBS-derived corona complexes lacked murine-specific "alarm signals", thereby attenuating reactive oxygen species generation and polarizing macrophages toward M2 phenotype both in vitro and in vivo. Consequently, the MS-derived corona conferred no significant osteogenic effect, whereas the FBS-derived corona markedly enhanced osteogenic differentiation. We propose that the FBS corona acts as a physical barrier, preventing subsequent adsorption of host alarm signals onto MWCNTs, thereby suppressing immunogenicity and enhancing osteogenesis. These findings highlight a critical limitation of using FBS in conventional in vitro models for predicting in vivo immune responses, and underscore the decisive role of species-specific immune recognition in determining the osteogenic fate of biomaterials.
Indexed as
Identifiers
42700220What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.